Veizaga Marvin 4
4 · CROSS COUNTRY HEALTHCARE INC · Filed Jul 21, 2026
Research Summary
AI-generated summary of this filing
Cross Country Healthcare (CCRN) CAO Marvin Veizaga Sells Shares
What Happened
- Marvin Veizaga, Chief Accounting Officer of Cross Country Healthcare, had company shares converted into cash in connection with the company’s merger. Two dispositions to the issuer show 31,480 shares and 16,797 shares canceled at $13.25 per share for proceeds of $417,110 and $222,560, respectively (total proceeds $639,670). The filing also shows a corresponding award/acquisition of 16,797 restricted shares at $0.00, reflecting vesting/cancellation treatment prior to cash conversion.
Key Details
- Transaction date: 2026-07-21. Price (Merger Consideration): $13.25 per share.
- Dispositions: 31,480 shares → $417,110; 16,797 shares → $222,560. Total cash received: $639,670 for 48,277 shares.
- Acquisition entry: 16,797 restricted shares shown as granted/converted at $0.00 (reflects vesting/cancellation under merger terms).
- Footnotes: Transactions occurred under the May 6, 2026 Merger Agreement—each outstanding common share was converted into the right to receive $13.25 in cash; restricted and performance-based awards vested (at target) and were cancelled for cash equal to shares × $13.25.
- Shares owned after the transactions: not specified in the filing. Filing date equals transaction date (timely).
Context
- These are merger-related conversions rather than open-market sales. Disposition code "D" (to issuer) indicates shares were surrendered/cancelled in the merger for cash consideration. The award entry (code "A") shows restricted/performance awards vested and were converted to cash per the merger terms. Such filings reflect deal payouts rather than a trading decision by the insider.
Insider Transaction Report
Form 4Exit
Veizaga Marvin
Chief Accounting Officer
Transactions
- Disposition to Issuer
Common Stock
[F1][F2]2026-07-21$13.25/sh−31,480$417,110→ 0 total - Award
Common Stock
[F3]2026-07-21+16,797→ 16,797 total - Disposition to Issuer
Common Stock
[F1][F2][F3]2026-07-21$13.25/sh−16,797$222,560→ 0 total
Footnotes (3)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2)
- [F2]at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration.
- [F3]At the Effective Time, each performance-based restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested (at target levels) and cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award (at target) immediately prior to the Effective Time multiplied by the Merger Consideration.
Signature
/s/ Marvin Veizaga|2026-07-21